https://www.selleckchem.com/pr....oducts/almorexant-hc
SECONDARY OUTCOMES pain during movement, neck disability, range of motion, pressure pain threshold, temporal summation, conditioned pain modulation, depressive symptoms, pain catastrophizing, quality of life, analgesic intake, and global perceived effect at posttreatment (10 sessions). Pain intensity and global perceived effect will also be measured after 6 weeks randomization. DISCUSSION The findings of this study might clarify the importance of using the photobiomodulation therapy and transcutaneous electrical nerve stimulation
Like
Comment
Share
